A detailed history of Osborne Partners Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Osborne Partners Capital Management, LLC holds 12,425 shares of AMGN stock, worth $3.28 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
12,425
Previous 12,365 0.49%
Holding current value
$3.28 Million
Previous $3.86 Million 3.62%
% of portfolio
0.23%
Previous 0.23%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$309.38 - $337.38 $18,562 - $20,242
60 Added 0.49%
12,425 $4 Million
Q3 2023

Oct 26, 2023

SELL
$218.65 - $271.46 $43,730 - $54,291
-200 Reduced 1.59%
12,365 $3.32 Million
Q2 2022

Aug 01, 2022

SELL
$230.71 - $256.74 $48,449 - $53,915
-210 Reduced 1.64%
12,565 $3.06 Million
Q1 2021

Apr 27, 2021

BUY
$221.91 - $258.6 $77,668 - $90,510
350 Added 2.82%
12,775 $3.18 Million
Q4 2020

Feb 01, 2021

BUY
$216.38 - $257.67 $2.69 Million - $3.2 Million
12,425 New
12,425 $2.86 Million
Q4 2019

Jan 27, 2020

SELL
$189.21 - $243.2 $780,491 - $1 Million
-4,125 Closed
0 $0
Q3 2019

Oct 25, 2019

BUY
$174.11 - $208.62 $21,763 - $26,077
125 Added 3.13%
4,125 $798,000
Q2 2019

Jul 18, 2019

SELL
$166.7 - $195.41 $33,340 - $39,082
-200 Reduced 4.76%
4,000 $737,000
Q1 2019

Apr 24, 2019

SELL
$180.87 - $203.88 $2.29 Million - $2.58 Million
-12,679 Reduced 75.12%
4,200 $798,000
Q3 2018

Oct 26, 2018

SELL
$185.29 - $208.89 $19,640 - $22,142
-106 Reduced 0.62%
16,879 $3.5 Million
Q2 2018

Jul 19, 2018

BUY
$166.05 - $186.51 $9,298 - $10,444
56 Added 0.33%
16,985 $3.14 Million
Q1 2018

Apr 19, 2018

SELL
$169.43 - $198.0 $15,926 - $18,612
-94 Reduced 0.55%
16,929 $2.89 Million
Q3 2017

Oct 19, 2017

BUY
$167.29 - $191.0 $2.85 Million - $3.25 Million
17,023
17,023 $3.17 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Osborne Partners Capital Management, LLC Portfolio

Follow Osborne Partners Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osborne Partners Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Osborne Partners Capital Management, LLC with notifications on news.